4//SEC Filing
BB BIOTECH AG 4
Accession 0000950170-24-042010
CIK 0001183765other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 8:13 PM ET
Size
11.1 KB
Accession
0000950170-24-042010
Insider Transaction Report
Form 4
BIOTECH TARGET N V
10% Owner
Transactions
- Purchase
Common Stock
2024-04-02$2.35/sh+250,000$587,500→ 1,279,820 total - Purchase
Prefunded Warrants (right to buy)
2024-04-02$2.35/sh+134,667$316,333→ 134,667 totalExercise: $0.00From: 2024-04-02Exp: 2029-04-02→ Common Stock (134,667 underlying) - Purchase
Common Warrants (right to buy)
2024-04-02$0.13/sh+769,334$96,167→ 769,334 totalExercise: $2.35From: 2024-04-02→ Common Stock (769,334 underlying)
BB BIOTECH AG
10% Owner
Transactions
- Purchase
Common Stock
2024-04-02$2.35/sh+250,000$587,500→ 1,279,820 total - Purchase
Prefunded Warrants (right to buy)
2024-04-02$2.35/sh+134,667$316,333→ 134,667 totalExercise: $0.00From: 2024-04-02Exp: 2029-04-02→ Common Stock (134,667 underlying) - Purchase
Common Warrants (right to buy)
2024-04-02$0.13/sh+769,334$96,167→ 769,334 totalExercise: $2.35From: 2024-04-02→ Common Stock (769,334 underlying)
Footnotes (1)
- [F1]The Common Warrants have a term of five years and the Prefunded Warrants will expire when fully exercised in accordance with their terms. The Prefunded and Common Warrants may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed 19.99% of the number of the shares of Common Stock outstanding immediately following such exercise.
Documents
Issuer
Molecular Templates, Inc.
CIK 0001183765
Entity typeother
IncorporatedSwitzerland
Related Parties
1- filerCIK 0000924223
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 8:13 PM ET
- Size
- 11.1 KB